Galectin Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Galectin Therapeutics Inc
Access all reports
Galectin Therapeutics Inc. is a biotechnology company that focuses on the development of therapies for fibrotic diseases, cancer, and other conditions related to galectin proteins. The company's research and development efforts are primarily centered on galectin-3, a protein that plays a critical role in various disease processes, including fibrosis and immune response. Galectin Therapeutics aims to create novel treatments that can potentially address unmet medical needs in these areas. The company is headquartered in Norcross, Georgia, and its shares are listed on the NASDAQ.
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
GALT
Country
🇺🇸 United States